Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

RNAC

Cartesian Therapeutics Inc

Sep 20 • 04:00PM ET

16.03

Dollar change -0.51
Percentage change -3.08	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: IWM VTI IWO VXF VTWO IWC VTWG RSSL JFWD URTY

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-53.26	Insider Own	52.13%	Shs Outstand	21.39M	Perf Week	-4.30%
Market Cap	342.88M	Forward P/E	-	EPS next Y	-3.44	Insider Trans	0.31%	Shs Float	10.24M	Perf Month	7.73%
Income	-267.20M	PEG	-	EPS next Q	-0.75	Inst Own	14.27%	Short Float	19.65%	Perf Quarter	-29.69%
Sales	54.10M	P/S	6.34	EPS this Y	90.65%	Inst Trans	55.01%	Short Ratio	13.87	Perf Half Y	-24.08%
Book/sh	-5.69	P/B	-	EPS next Y	26.05%	ROA	-109.68%	Short Interest	2.01M	Perf Year	-50.06%
Cash/sh	4.08	P/C	3.93	EPS next 5Y	-	ROE	-49.79%	52W Range	11.66 - 42.60	Perf YTD	-22.49%
Dividend Est.	-	P/FCF	-	EPS past 5Y	10.69%	ROI	-	52W High	-62.37%	Beta	0.64
Dividend TTM	-	Quick Ratio	3.03	Sales past 5Y	230.86%	Gross Margin	95.10%	52W Low	37.42%	ATR (14)	1.32
Dividend Ex-Date	-	Current Ratio	4.78	EPS Y/Y TTM	-672.36%	Oper. Margin	-89.99%	RSI (14)	54.10	Volatility	8.48% 8.34%
Employees	38	Debt/Eq	-	Sales Y/Y TTM	11.11%	Profit Margin	-493.88%	Recom	1.29	Target Price	41.60
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	124.26%	Payout	-	Rel Volume	0.78	Prev Close	16.54
Sales Surprise	403.34%	EPS Surprise	162.58%	Sales Q/Q	537.17%	Earnings	Aug 08 BMO	Avg Volume	145.07K	Price	16.03
SMA20	9.42%	SMA50	5.34%	SMA200	-21.80%	Trades		Volume	113,218	Change	-3.08%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-06-24	Initiated	TD Cowen	Buy
Jul-02-24	Downgrade	Oppenheimer	Outperform → Perform
Jun-04-24	Initiated	Oppenheimer	Outperform	$50
May-24-24	Initiated	Mizuho	Buy	$40
Apr-23-24	Reiterated	H.C. Wainwright	Buy	$2 → $54
Apr-23-24	Initiated	Leerink Partners	Outperform	$39
Aug-18-23	Downgrade	SVB Securities	Outperform → Market Perform	$1
Jun-14-22	Reiterated	Needham	Buy	$6 → $5
Jun-06-22	Initiated	SVB Leerink	Outperform	$7
Jun-15-21	Initiated	BTIG Research	Buy	$10
Jan-26-21	Upgrade	Mizuho	Neutral → Buy	$2.50 → $8
Oct-01-20	Downgrade	William Blair	Outperform → Mkt Perform
Oct-01-20	Downgrade	Mizuho	Buy → Neutral	$2.50
Jun-12-20	Downgrade	Stifel	Buy → Hold
Apr-28-20	Initiated	H.C. Wainwright	Buy	$8
Jan-29-20	Initiated	Cantor Fitzgerald	Overweight	$10
Jan-21-20	Initiated	William Blair	Outperform
Jun-27-18	Initiated	Janney	Buy	$33
Mar-30-17	Reiterated	UBS	Buy	$26

Show Previous Ratings

Sep-09-24 07:00AM	Cartesian Therapeutics Receives FDA Rare Pediatric Disease Designation for Descartes-08 for the Treatment of Juvenile Dermatomyositis (GlobeNewswire)
Sep-06-24 07:05AM	Cartesian Therapeutics Announces New Employment Inducement Grant (GlobeNewswire) -7.55%
Sep-03-24 07:00AM	Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15 (GlobeNewswire) -6.02%
Aug-26-24 07:00AM	Cartesian Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-08-24 07:00AM	Cartesian Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire) -9.43%
04:05PM	Loading…
Aug-07-24 04:05PM	Cartesian Therapeutics Announces New Employment Inducement Grants (GlobeNewswire)
Jul-08-24 04:05PM	Cartesian Therapeutics Announces New Employment Inducement Grants (GlobeNewswire)
Jul-03-24 02:25PM	Cartesian (RNAC) MG Study Meets Goals, Stock Down on Other Updates (Zacks) +11.73%
Jul-02-24 04:08PM	Cartesian Therapeutics Plummets Despite 'Watershed Moment' For CAR-T Drugs (Investor's Business Daily) -35.02%
04:05PM	Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik (GlobeNewswire)
06:31AM	Cartesian Therapeutics Announces First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic Lupus Erythematosus (GlobeNewswire)
06:31AM	Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing (GlobeNewswire)
06:30AM	Cartesian Therapeutics Announces Positive Topline Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis (GlobeNewswire)
Jun-06-24 07:05AM	Cartesian Therapeutics Announces New Employment Inducement Grant (GlobeNewswire)
May-23-24 12:12PM	Cartesian (RNAC) Up as FDA Grants RMAT Tag to Descartes-08 (Zacks)
07:00AM	Loading…
May-22-24 07:00AM	Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis (GlobeNewswire)
May-13-24 04:30PM	Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ (GlobeNewswire) +15.38%
12:00PM	What Makes Cartesian Therapeutics, Inc. (RNAC) a New Buy Stock (Zacks)
09:55AM	Wall Street Analysts Think Cartesian Therapeutics, Inc. (RNAC) Could Surge 141%: Read This Before Placing a Bet (Zacks)
May-10-24 03:12PM	Cartesian Therapeutics Inc (RNAC) Reports Q1 2024 Earnings: A Detailed Financial and ... (GuruFocus.com)
May-08-24 02:52PM	RNAC Stock Earnings: Cartesian Therapeutics Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
07:00AM	Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-06-24 04:15PM	Cartesian Therapeutics Announces New Employment Inducement Grants (Business Wire) -9.85%
Apr-25-24 09:55AM	Wall Street Analysts Believe Cartesian Therapeutics, Inc. (RNAC) Could Rally 146.24%: Here's is How to Trade (Zacks)
Apr-22-24 04:30PM	Cartesian Therapeutics to Present at the ASGCT 27th Annual Meeting (Business Wire) +12.76%
Apr-08-24 09:35AM	Down -30.75% in 4 Weeks, Here's Why You Should You Buy the Dip in Cartesian Therapeutics, Inc. (RNAC) (Zacks)
Apr-04-24 07:30AM	Cartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference (Business Wire)
07:00AM	Cartesian Therapeutics Announces New Employment Inducement Grants (Business Wire)
Apr-02-24 05:41PM	Insiders Are Buying These 11 Penny Stocks (Insider Monkey) -5.36% -7.55%
Mar-28-24 04:05PM	Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split (GlobeNewswire) -13.83%
09:35AM	Loading…
Mar-14-24 09:35AM	Cartesian Therapeutics, Inc. (RNAC) Loses -24.65% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Mar-07-24 11:51PM	RNAC Stock Earnings: Cartesian Therapeutics Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) -8.04%
07:00AM	Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-06-24 07:00AM	Cartesian Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Mar-05-24 07:05AM	Cartesian Therapeutics Announces New Employment Inducement Grant (GlobeNewswire)
07:00AM	Cartesian Therapeutics Establishes New Corporate Headquarters and State-of-the-Art mRNA Cell Therapy cGMP Manufacturing Facility in Frederick, Maryland (GlobeNewswire)
Feb-05-24 04:05PM	Cartesian Therapeutics Announces New Employment Inducement Grants (GlobeNewswire) -9.18% +5.35%
Jan-22-24 09:19AM	Why Is Cartesian Therapeutics (RNAC) Stock Down 5% Today? (InvestorPlace)
Jan-08-24 07:10AM	Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity (GlobeNewswire) +5.87%
07:00AM	Cartesian Therapeutics Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia Gravis (GlobeNewswire)
Nov-13-23 08:05AM	Selecta Biosciences Announces Merger with Cartesian Therapeutics (GlobeNewswire) -8.00%
Oct-31-23 04:03PM	Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner Sobi (GlobeNewswire) -7.20%
Aug-24-23 06:21AM	The Petri Dish: Selecta gets selective with drug programs; Moderna enters 2nd cancer vaccine collab (American City Business Journals)
Aug-17-23 10:20PM	Q2 2023 Selecta Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
08:15AM	Selecta Biosciences, Inc. (SELB) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Selecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiative Designed to Maximize Stockholder Value Associated with SEL-212 Economics (GlobeNewswire)
Jul-14-23 07:08AM	Selecta Biosciences, Inc.'s (NASDAQ:SELB) largest shareholders are individual investors with 35% ownership, institutions own 26% (Simply Wall St.)
Jul-13-23 03:00PM	10 Best Revenue Growth Stocks to Buy (Insider Monkey)
Jun-03-23 08:20AM	Selecta Biosciences (NASDAQ:SELB) shareholders are up 22% this past week, but still in the red over the last five years (Simply Wall St.)
May-31-23 07:00AM	Selecta Biosciences Announces Presentation of Data from Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout During Late-Breaking Session at the EULAR 2023 European Congress of Rheumatology (GlobeNewswire)
May-09-23 06:06AM	Newsflash: Selecta Biosciences, Inc. (NASDAQ:SELB) Analysts Have Been Trimming Their Revenue Forecasts (Simply Wall St.)
May-04-23 08:45AM	Selecta Biosciences, Inc. (SELB) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -6.96%
07:30AM	Selecta Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Apr-28-23 04:05PM	Selecta Biosciences to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update (GlobeNewswire) -5.04%
Apr-18-23 06:11AM	Investors Holding Back On Selecta Biosciences, Inc. (NASDAQ:SELB) (Simply Wall St.)
Mar-27-23 07:07AM	Is Selecta Biosciences, Inc.'s (NASDAQ:SELB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? (Simply Wall St.) -5.67%
Mar-21-23 11:48AM	Selecta, SOBI's Chronic Refractory Gout Program Meets Primary Goal, US Submission Expected Next Year (Benzinga)
03:30AM	Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout Meets Primary Endpoint (GlobeNewswire)
Mar-06-23 05:59AM	Selecta Biosciences, Inc. (NASDAQ:SELB) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-03-23 01:24AM	Q4 2022 Selecta Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-02-23 09:25AM	Selecta Biosciences, Inc. (SELB) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Selecta Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire)
Feb-23-23 08:00AM	Selecta Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2022 Financial Results and Provide Business Update (GlobeNewswire)
Feb-07-23 01:51PM	The 7 Best Biotech Stocks to Buy for February 2023 (InvestorPlace)
08:00AM	Selecta Biosciences to Participate at the SVB Securities Global Biopharma Conference (GlobeNewswire)
Jan-31-23 01:15PM	Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts (Benzinga)
Jan-17-23 11:33AM	Positive week for Selecta Biosciences, Inc. (NASDAQ:SELB) institutional investors who lost 34% over the past year (Simply Wall St.)
Jan-12-23 05:39AM	The Petri Dish: Moderna looks at new price tag for Covid vaccine (American City Business Journals) +5.44%
Jan-09-23 08:00AM	Selecta Biosciences Provides Business Update and Outlook for 2023 (GlobeNewswire) +8.13%
07:30AM	Selecta Biosciences and Astellas Announce Exclusive Licensing and Development Agreement for Xork IgG Protease (PR Newswire)
Dec-21-22 10:29AM	Shareholders in Selecta Biosciences (NASDAQ:SELB) have lost 89%, as stock drops 19% this past week (Simply Wall St.)
Dec-14-22 08:00AM	Selecta Biosciences Announces Next Generation IgA Protease Clinical Candidate Selection for IgA Nephropathy Program (GlobeNewswire)
Dec-01-22 05:43AM	The Petri Dish: bluebird gets $102M; BMS vet joins Selecta's C-suite (American City Business Journals)
Nov-28-22 08:00AM	Selecta Biosciences Announces Appointment of Blaine Davis as Chief Financial Officer (GlobeNewswire)
Nov-09-22 06:36AM	Selecta Biosciences Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.) -8.39%
Nov-07-22 08:00AM	Selecta Biosciences to Participate at the Guggenheim Healthcare Talks \| 4th Annual Immunology & Neurology Day (GlobeNewswire)
Nov-03-22 09:15AM	Selecta Biosciences, Inc. (SELB) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
08:00AM	Selecta Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Oct-27-22 08:00AM	Selecta Biosciences to Host Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results and Provide Business Update (GlobeNewswire)
Oct-18-22 06:13AM	Could The Market Be Wrong About Selecta Biosciences, Inc. (NASDAQ:SELB) Given Its Attractive Financial Prospects? (Simply Wall St.)
Oct-11-22 08:00AM	Selecta Biosciences Announces Three Presentations at the Upcoming 29th Annual European Society of Gene and Cell Therapy (ESGCT) Conference (GlobeNewswire) +7.89%
Oct-10-22 06:10PM	Elevance Health's (ELV) Low-Cost MA Plans to Widen U.S. Base (Zacks) -7.88%
Sep-29-22 08:00AM	Selecta Biosciences Board Member, Timothy Springer, Ph.D., Wins Lasker Award for Seminal Discovery of Key Adhesion Molecules that Mediate Immune Cell Interactions (GlobeNewswire) -5.29%
Sep-12-22 08:00AM	Selecta Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Sep-06-22 08:00AM	Selecta Biosciences to Participate at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-30-22 06:21AM	Selecta Biosciences (NASDAQ:SELB) Has A Pretty Healthy Balance Sheet (Simply Wall St.)
Aug-29-22 05:08PM	This Small-Cap Biotech is a Sneaky Play on Next-Gen Drugs (TheStreet.com)
Aug-12-22 09:30AM	10 Best One Dollar Stocks To Buy Now (Insider Monkey)
Aug-09-22 10:25AM	Need To Know: Analysts Are Much More Bullish On Selecta Biosciences, Inc. (NASDAQ:SELB) (Simply Wall St.)
Aug-06-22 08:25AM	What Kind Of Investors Own Most Of Selecta Biosciences, Inc. (NASDAQ:SELB)? (Simply Wall St.)
Aug-04-22 09:05AM	Selecta Biosciences, Inc. (SELB) Q2 Earnings and Revenues Surpass Estimates (Zacks) +13.94%
07:30AM	Selecta Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Aug-01-22 08:00AM	Selecta Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jul-28-22 12:00PM	Selecta Biosciences, Inc. (SELB) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
08:00AM	Selecta Biosciences to Host Conference Call and Webcast to Discuss Second Quarter 2022 Financial Results and Provide Business Update (GlobeNewswire)
Jul-19-22 09:19AM	Top 10 Multibagger Penny Stocks to Buy in 2022 (Insider Monkey)
Jul-14-22 09:03AM	Strong week for Selecta Biosciences (NASDAQ:SELB) shareholders doesn't alleviate pain of five-year loss (Simply Wall St.) -7.34%
Jul-12-22 07:49AM	Vertex (VRTX) to Buy ViaCyte to Speed Up VX-880 Program (Zacks) +8.07%
Jul-06-22 08:00AM	Selecta Biosciences to Participate at the Guggenheim I&I Spotlight Series Treg-based Therapies Conference (GlobeNewswire)
Jun-29-22 07:00AM	Surface Oncology Appoints Carsten Brunn to Board of Directors (GlobeNewswire)

Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company is headquartered in Gaithersburg, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SPRINGER TIMOTHY A	Director	Aug 12 '24	Buy	12.72	8,016	101,968	11,509	Aug 14 04:43 PM
BARABE TIMOTHY C	Director	Aug 12 '24	Buy	12.70	7,500	95,250	21,766	Aug 14 04:41 PM
SPRINGER TIMOTHY A	Director	Mar 08 '24	Buy	0.66	4,800	3,187	95,218	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 13 '24	Buy	0.58	3,200	1,868	100,818	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Feb 07 '24	Buy	0.66	2,400	1,575	90,418	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 14 '24	Buy	0.53	2,000	1,061	102,818	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 11 '24	Buy	0.65	1,200	785	96,418	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 12 '24	Buy	0.61	1,200	735	97,618	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 15 '24	Buy	0.56	1,200	672	104,018	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Jan 17 '24	Buy	0.69	800	552	87,218	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Feb 06 '24	Buy	0.65	800	520	88,018	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 18 '24	Buy	0.61	800	488	104,818	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 26 '24	Option Exercise	1.46	1,970,443	2,876,847	33,043,849	Mar 26 04:32 PM
SPRINGER TIMOTHY A	Director	Mar 18 '24	Buy	0.60	19,044	11,398	31,073,406	Mar 20 05:09 PM
SPRINGER TIMOTHY A	Director	Mar 14 '24	Buy	0.54	648,372	351,677	30,516,862	Mar 18 05:29 PM
SPRINGER TIMOTHY A	Director	Mar 15 '24	Buy	0.59	537,500	314,545	31,054,362	Mar 18 05:29 PM
Brunn Carsten	President and CEO	Sep 25 '23	Sale	1.06	2,932	3,108	783,081	Sep 26 06:01 PM
TRABER PETER G	Chief Medical Officer	Sep 25 '23	Sale	1.06	705	747	451,826	Sep 26 06:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RNAC

Cartesian Therapeutics Inc

Upgrade your FINVIZ experience